GEODE CAPITAL MANAGEMENT, LLC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$23,960,814
+49.3%
1,045,057
+7.4%
0.00%
+50.0%
Q2 2023$16,050,546
+90.3%
973,350
+105.9%
0.00%
+100.0%
Q1 2023$8,434,062
+63071.8%
472,761
+3.1%
0.00%
-50.0%
Q4 2022$13,351
-99.9%
458,510
+18.1%
0.00%
+100.0%
Q3 2022$9,508,000
+473.1%
388,112
-2.9%
0.00%
Q2 2022$1,659,000
-80.6%
399,794
-46.0%
0.00%
-100.0%
Q1 2022$8,535,000
+19.8%
740,889
+3.8%
0.00%0.0%
Q4 2021$7,125,000
-18.3%
714,028
+6.9%
0.00%0.0%
Q3 2021$8,719,000
-35.0%
667,658
-2.5%
0.00%
-50.0%
Q2 2021$13,410,000
+1.1%
684,903
+9.8%
0.00%0.0%
Q1 2021$13,263,000
-8.7%
623,562
+27.7%
0.00%0.0%
Q4 2020$14,521,000
+36.3%
488,447
-0.7%
0.00%0.0%
Q3 2020$10,654,000
+0.2%
491,679
+3.1%
0.00%0.0%
Q2 2020$10,631,000
+57.6%
476,750
+7.6%
0.00%0.0%
Q1 2020$6,746,000
-63.1%
443,257
-44.3%
0.00%0.0%
Q4 2019$18,270,000
+166.8%
795,750
+150.8%
0.00%0.0%
Q3 2019$6,849,000
-0.4%
317,273
+1.5%
0.00%0.0%
Q2 2019$6,875,000
-0.5%
312,536
+24.0%
0.00%0.0%
Q1 2019$6,907,000
-45.1%
252,017
-46.1%
0.00%0.0%
Q4 2018$12,574,000
+140.0%
467,788
+160.4%
0.00%
+100.0%
Q3 2018$5,240,000
+84.6%
179,647
+97.8%
0.00%0.0%
Q2 2018$2,839,000
+19.5%
90,828
-23.9%
0.00%0.0%
Q1 2018$2,375,000
-34.0%
119,358
-3.6%
0.00%0.0%
Q4 2017$3,597,000123,7950.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders